Evidence map›Paper›PMID 31702088›Full record

ArticleJournal of the International AIDS Society2019

Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration.

Julie Jesson, Michael Schomaker, Karen Malasteste, Dewi K Wati, Azar Kariminia, Mariam Sylla, Kouakou Kouadio, Shobna Sawry, Mwangelwa Mubiana-Mbewe, Samuel Ayaya and 6 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Evaluation of submaximal endurance in young children living with HIV.The South African journal of physiotherapy · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Transition to Dolutegravir Is Associated With an Increase in the Rate of Body Mass Index Change in a Cohort of Virally Suppressed Adolescents.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 9 countries.

Julie JessonInserm U1027, Université Paul Sabatier Toulouse 3, Toulouse, France.ORCID 0000-0002-9461-2520
Michael SchomakerUniversity of Cape Town, Centre for Infectious Disease Epidemiology and Research, Cape Town, South Africa.ORCID 0000-0002-8475-0591
Karen MalastesteInserm U1219, Bordeaux Population Health Center, Université de Bordeaux, Bordeaux, France.
Dewi K WatiSanglah Hospital, Bali, Indonesia.
Azar KariminiaThe Kirby Institute, UNSW, Sydney, Australia.
Mariam SyllaHopital Gabriel Touré, Bamako, Mali.ORCID 0000-0002-8853-4132
Kouakou KouadioCIRBA, Abidjan, Côte d'Ivoire.
Shobna SawryHarriet Shezi Children's Clinic, Chris Hani Baragwanath Academic Hospital, Soweto, South Africa.ORCID 0000-0002-3845-4863
Mwangelwa Mubiana-MbeweCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID 0000-0002-7122-842X
Samuel AyayaDepartment of Child Health and Paediatrics, School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya.
Rachel VreemanRyan White Center for Pediatric Infectious Disease and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0001-5460-8204
Catherine C McGowanVanderbilt University School of Medicine, Nashville, TN, USA.
Marcel YotebiengDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.ORCID 0000-0003-2110-2631
Valériane LeroyInserm U1027, Université Paul Sabatier Toulouse 3, Toulouse, France.ORCID 0000-0003-3542-8616
Mary-Ann DaviesUniversity of Cape Town, Centre for Infectious Disease Epidemiology and Research, Cape Town, South Africa.ORCID 0000-0001-8496-6475
IeDEA global cohort consortium
Université Toulouse III - Paul Sabatier · FRUniversity of Cape Town · ZACentre for Infectious Disease Research in Zambia · ZMIndiana University School of MedicineMali-Folkecenter · MLMoi University · KERumah Sakit Umum Pusat Sanglah Denpasar · IDThe Ohio State University · USUniversité de Bordeaux · FRUniversity of the Witwatersrand · ZAUNSW Sydney · AUVanderbilt University · US

Funding

East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional ConsortiumU01AI069911 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI AGGREY SEMWENDERO SEMEERE, Kara Kay Wools-Kaloustian · 2006 to 2026
$57.7M
Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
The Asia-Pacific HIV Research CollaborationU01AI069907 · NIAID · FOUNDATION FOR AIDS RESEARCH · PI ANNETTE H SOHN · 2006 to 2026
$44.8M
CCASAnet: Caribbean, Central and South America NetworkU01AI069923 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pedro Enrique Cahn, Jessica L Castilho · 2006 to 2026
$41.6M
"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
WADA (West Africa Database on Antiretroviral Therapy) CollaborationU01AI069919 · NIAID · UNIVERSITY OF BORDEAUX II · PI Didier Koumavi Ekouevi, Antoine Jaquet · 2006 to 2026
$29.9M
Action intentions in nonvisual spatial updatingR03MH069907 · NIMH · MIAMI UNIVERSITY OXFORD · PI LIPPA, YVONNE · 2004 to 2005
$142k
Physical Activity &Mental Health: MultidisciplinaryR13MH069911 · NIMH · COOPER INSTITUTE · PI CHAMBLISS, HEATHER O · 2003 to 2003
$25k
NIAID NIH HHS U01 AI069907NIAID NIH HHS U01 AI069911NIAID NIH HHS U01 AI069919NIAID NIH HHS U01 AI069923NIAID NIH HHS U01 AI069924NIAID NIH HHS U01 AI096299
6 · The paper itself

Abstract

introductionStunting is a key issue for adolescents with perinatally acquired HIV (APH) that needs to be better understood. As part of the IeDEA multiregional consortium, we described growth evolution during adolescence for APH on antiretroviral therapy (ART).

methodsWe included data from sub-Saharan Africa, the Asia-Pacific, and the Caribbean, Central and South America regions collected between 2003 and 2016. Adolescents on ART, reporting perinatally acquired infection or entering HIV care before 10 years of age, with at least one height measurement between 10 and 16 years of age, and followed in care until at least 14 years of age were included. Characteristics at ART initiation and at 10 years of age were compared by sex. Correlates of growth defined by height-for-age z-scores (HAZ) between ages 10 and 19 years were studied separately for males and females, using linear mixed models.

resultsOverall, 8737 APH were included, with 46% from Southern Africa. Median age at ART initiation was 8.1 years (interquartile range (IQR) 6.1 to 9.6), 50% were females, and 41% were stunted (HAZ<-2 SD) at ART initiation. Males and females did not differ by age and stunting at ART initiation, CD4 count over time or retention in care. At 10 years of age, 34% of males were stunted versus 39% of females (p < 0.001). Females had better subsequent growth, resulting in a higher prevalence of stunting for males compared to females by age 15 (48% vs. 25%) and 18 years (31% vs. 15%). In linear mixed models, older age at ART initiation and low CD4 count were associated with poor growth over time (p < 0.001). Those stunted at 10 years of age or at ART initiation had the greatest growth improvement during adolescence.

conclusionsPrevalence of stunting is high among APH worldwide. Substantial sex-based differences in growth evolution during adolescence were observed in this global cohort, which were not explained by differences in age of access to HIV care, degree of immunosuppression or region. Other factors influencing growth differences in APH, such as differences in pubertal development, should be better documented, to guide further research and inform interventions to optimize growth and health outcomes among APH.

Indexed as

Growth DisordersAdolescentAdolescent DevelopmentChildCohort StudiesFemaleGlobal HealthHIV InfectionsHumansMalePrevalenceSex CharacteristicsTime Factorsadolescentcohort studiesdeveloping countriesgrowthHIVstunting

Identifiers

PMID31702088
PMCPMC6839428
OpenAlexW2988828471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.